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Longitudinal Study on Oral Health in
Subjects with Alzheimer's Disease
Jonathan A. Ship, DMD and ScottA. Puckett, BS
Objective: To examine longitudinal oral health changes in
unmedicated, generally healthy subjects with Alzheimer's
disease (AD) and compare them to age- and gender-matched
healthy, unmedicated control subjects.
Design: Oral health parameters were evaluated over 2 to 3
years and the results compared between subjects with AD
and controls.
Setting: Clinical Center of the National Institutes of Health,
Bethesda, Maryland.
Participants: Twenty-one community-dwelling subjects with
a clinical diagnosis of AD and 21 age- and gender-matched
control subjects. Neither population was being treated for
any other systemic condition nor taking any prescription
medications.
~zheimer's disease (AD) is the most common formof dementia among the elderly, accounting forabout 50% to 60% of people with loss of cog-
nitive function.' The incidence of AD increases dra-
matically with age, from about 0.1 % at age 60 to 65 to
as high as 47% at age 85.2 It is a degenerative neuro-
logical disorder characterized by progressive impair-
ments in a wide range of co~itive abilities, from
memory to abstract reasoning." Behavioral and func-
tional symptoms often accompany the above-men-
tioned impairments, resulting in severe consequences
to many organ systems."
With the increasing percentage of the population
over age 65, the number of individuals with Alz-
heimer's disease will also grow. Presently, there is no
known effective treatment for the functional and in-
tellectual degeneration resulting from the disease proc-
ess. Most treatment efforts are generally care oriented,
as opposed to cure oriented, and are directed to provide
relief of physical, psychological, and emotional prob-
lems associated with the progressing disease.'
The oral cavity serves several essential functions
(deglutition, host defense, and communication), yet
frequently oral health is neglected in patients with
terminal and incapacitating disorders. Although re-
search advances have increased the understanding of
AD, there are few reports of the effects of AD and its
progression on oral health. Previous cross-sectional
studies have demonstrated diminished salivary gland
function and altered gingival and dental health in
unmedicated patients with AD.5• 6 Other reviews have
recommended the establishment of early preventive
and maintenance oral health regimens in patients with
AD and other neurodegenerative disorders." 7-10 To our
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Measurements: Unstimulated and stimulated major salivary
gland flow rates were measured, and gingival, periodontal,
dental, and oral mucosal tissues assessed.
Main Results: In general, subjects with AD demonstrated
decreased salivary flow rates and diminished oral health, but
most longitudinal changes in oral health status were not
significantly different than controls.
Conclusions: Patients with AD are susceptible to a variety
of oral health problems, and progression of AD can lead to a
deterioration in oral health and function. These patients
require aggressive preventive care to maintain function for
as long as possible, which necessitates close cooperation
among numerous health care professionals. J Am Geriatr
Soc 42:57-63,1994
knowledge, however, there have been no longitudinal
studies published on oral health in patients with AD.
These data would be useful to devise appropriate clin-
ical recommendations for the maintenance of oral
health and function in these patients and to preserve
their quality of life for as long as possible. Accordingly,
the purpose of this investigation was to examine lon-
gitudinal changes in salivary, gingival, periodontal,
dental, and oral mucosal parameters in unmedicated,
essentially healthy subjects with AD.
MATERIALS AND METHODS
Population Twenty-one community dwelling sub-
jects in middle socio-economic status (13 men, 8
women) with a clinical diagnosis of AD were evaluated
at the Clinical Center of the National Institutes of
Health, Bethesda, Maryland, in a longitudinal study
sponsored by the National Institute on Aging (Table
1). A diagnosis was made according to NINCDS-
ADRDA criteria!' after subjects were screened vigor-
ously to exclude other medical, neurological, and psy-
chiatric conditions. All subjects were extensively eval-
uated with diagnostic radiographs, computed tomo-
graphic brain scans, magnetic resonance imaging,
positron emission tomo~aphy, and neuropsychologi-
cal and medical tests.F" 5 No subject was taking any
medication for systemic disease, nor being treated for
any other disorder. The Mini-Mental State Examination
(MMSE)16 was administered to each subject at each
visit to estimate the severity of cognitive impairment
(Table 1). The interval between visits for subjects with
AD was 23 ± 11 months (mean ± SD).
Twenty-one healthy subjects were selected as age-
and gender-matched control subjects (Table 1). All
were volunteer participants in a normative aging pro-
gram conducted by the National Institute on Aging.
These subjects were community dwelling, of middle
socio-economic status, healthy, not being treated for
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• Values areexpressed as mean ± SD.
t Statistical comparison between control subjects and Alzheimer's
subjects.
•• Mini-mental state exam; Folstein et al.I.
§ Significantly lower than visit 1 MMSE scores for Alzheimer's
(P = 0.0001).
any systemic disease nor taking any prescription med-
ications, and underwent rigorous medical, neurologi-
cal, and laboratory screening. 12. 17 The interval between
visits for control subjects was 36 ± 1.5 months (mean
± SD) (Table 1).
Oral Health Parameters All study subjects re-
ceived an interview and intraoral/extraoral clinical
examinatiori'Y'" by one investigator (J.A.S.). The ex-
aminer was not blinded to the status of the study
subject (AD vs control), but was unaware of the level
of dementia among AD subjects at the time of exami-
nation. Major salivary gland flow rates were deter-
mined according to previously described criteria." All
subjects refrained from eating, drinking, smoking, and
oral hygiene for a minimum of 90 minutes before saliva
collection. Unstimulated and stimulated saliva was col-
lected from one parotid gland with the use of a modi-
fied Carlson-Crittenden cup as described previously."
For any subject displaying no unstimulated parotid
saliva production after 5 minutes, a retest was per-
formed. Only after two negative unstimulated test re-
sults, plus positive evidence of a stimulated secretion,
was a subject considered to have an unstimulated flow
rate of zero." Submandibular saliva was collected from
the orifice of Wharton's duct, as previously described.l"
Salivary flow was stimulated by swabbing 2% citric
acid on the dorsolateral surfaces of the tongue at 30-
second intervals." After collection, the salivary volume
was determined gravimetrically, assuming a specific
gravity of 1.0. Submandibular saliva actually repre-
sents a combined submandibular/sublingual secretion
due to the frequent common exit of the gland ducts, 18.21
but will be referred to as submandibular saliva.
An examination of dental, gingival, periodontal, and
oral mucosal tissues was performed on all subjects,
according to previously described criteria." The number
of teeth (excluding third molars), decayed-missing-
filled-teeth score, and the number of teeth with cervical
and coronal caries and restorations were recorded."
The mesiobuccal, midbuccal, distobuccal, mesiolingual,
midlingual, and distolingual surfaces of the six teeth
proposed by Rarnfjord'" were examined for periodontal
parameters" according to National Institute of Dental
Research criteria." Briefly, the 36 tooth surfaces were
TABLE 1. STUDY POPULAnON*
Control Alzheimer's
Subjects Subjects
(n = 21) (n = 21)
assessed for the presence or absence of dental plaque,
gingival bleeding, and supra- or subgingival calculus.
The distance from the free gingival margin to the
cementoenamel junction and the distance from the free
gingival margin to the bottom of the sulcus or pocket
was measured with a National Institute of Dental
Research color-coded periodontal probe. The percent-
age of tooth surfaces for each subject with dental
plaque, gingival bleeding, and calculus was calculated
and the amounts of gingival recession, pocketing, and
level of attachment (LOA) were recorded. In addition,
the extent and severity of LOA were determined ac-
cording to criteria established by Carlos et al.2S All
intraoral structures were assessed with a modified mu-
cosal rating scale." Normal mucosal changes (dry, pale,
or glossy mucosa and alterations in mucosal topogr~­
phy) were rated 0, and any moderate or severe condi-
tions (erythemic or leukoplakic lesions, ulcerations, and
erosions) were rated 1.26 Oral candidal lesions
(atrophic, pseudomembranous, and denture stomati~s)
were diagnosed clinically" and grouped together With
a rating of 1.
Statistical analysis Intraexaminer replicate exam-
inations for periodontal pocket depth (SD = 0.38 mm)
and LOA (SD = 0.42 mm), and intraclass correlation
coefficients for unstimulated submandibular flow rate
(0.978) and stimulated submandibular flow rate (0.984)
were calculated on nine control subjects. Data from the
study were analyzed for differences between men and
women within each group, and between subjects with
AD and control subjects for each visit. The yearly
change in each oral health parameter was determined:
the change from the first to last visit for each subject
was divided by the number of months between visits,
and then multiplied by 12 months. A Student's t test
was used when mean values had a normal distribution,
and a Mann-Whitnel U procedure was used for non-
parametric values. X and two-way Fisher's Exact tests
were performed for prevalence data.
Correlation analyses were performed on subjects
with AD to determine whether a relation existed be-
tween level of dementia (as determined from the
MMSE score) at each visit and oral health parameters.
Correlations were also determined on AD subjects for
changes in dementia over time (change in MMSE score)
and change in oral health parameters. To determine
whether the relationship between age and change in
oral health was different between groups, regressions
were calculated for longitudinal change for each oral
health parameter and age at baseline, and compared
between the two groups. Data were analyzed using the
RS1 software package (BBN Software Products Corp,
Boston, MA). A criterion of P < 0.05 was accepted for
significance in all statistical tests.
RESULTS
Because no gender differences were observed for any
of the clinical parameters in either AD or control pop-
ulations, data for men and women were combined in
all subsequent analyses. In addition, regression anal-
yses for longitudinal changes in each oral health pa-
rameter and age at baseline were not statistically dif-
ferent between the two groups.
p**
0.0001
0.0001
0.0001
0.0001
18.9 ± 5.5
12.2 ± 9.2§
13 13
8 8
65 ± 12 64 ± 9
48-90 48-80
36 ± 1.5 23 ± 11
29.5 ± 0.7
29.3 ± 0.7
Men
Women
Age (y)
Age (range) (y)
Interval (mas)
MMSE scoresf
Visit 1
Visit 2
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FIGURE 1. Longitudinal parotid (top panel) and submandibular
(bottom panel) salivary gland flow rates in 21 unmedicated AD and
21 healthy control subjects. Results are expressed in milliliters per
minute per gland (mean ± SE) for all flow rates. Values for AD
subjects are extrapolated from the 1.9-year time point to the 3-year
time point. PI denotes unstimulated parotid flow, P2 stimulated
parotid, 51 unstimulated submandibular, and 52 stimulated subman-
dibular.
Major salivary gland flow rates in AD and control
groups at both visits are displayed in Figure 1. With
the exception of stimulated parotid flow rates at visit
1, subjects with AD had lower unstimulated and stim-
ulated major salivary gland flow rates at both visits.
Unstimulated (P = 0.02) and stimulated (P = 0.07)
submandibular flow rates were lower in subjects with
AD at visit 1, and unstimulated parotid (P = 0.05) and
stimulated submandibular (P = 0.05) flow rates were
lower at visit 2. Salivary flow rates increased over the
time interval in control subjects, but were only signif-
icant for unstimulated parotid flow (P = 0.04). Unstim-
ulated flow rates remained essentially stable in Alz-
heimer's subjects, whereas stimulated flow rates (pa-
rotid, P = 0.07; submandibular, P > 0.05) decreased
over time.
The average yearly changes in unstimulated (P =
0.06) and stimulated (P = 0.07) parotid flow rates
tended to be lower in subjects with AD compared with
control subjects (Table 2). There were no significant
differences for average yearly changes for submandib-
ular flow rates between the two groups. Analyses were
performed to determine if there was a relation between
MMSE scores and salivary gland flow rates. There were
positive correlations with submandibular flow rates but
none for parotid flow rates. With decreasing MMSE
scores, unstimulated submandibular (visit 1, r = 0.42,
P = 0.05; visit 2, r = 0.47, P < 0.05) and stimulated
submandibular (visit 2, r = 0.37, P = 0.09) flow rates
diminished. However, there were no significant corre-
lations between changes in salivary flow rates over the
time period and changes in MMSE scores.
Gingival health parameters were consistently worse
at both visits in subjects with AD compared with
control subjects (Figure 2). This was significant for the
percent of tooth surfaces with dental plaque (visit 1, P
= 0.003; visit 2, P = 0.007) and gingival bleeding (visit
2, P = 0.0001). Gingival health in Alzheimer and
control subjects worsened over time (with the exception
of gingival bleeding in controls), but there were no
statistical differences between the two groups (Table
2). For control subjects, percent plaque (P = 0.0001)
and calculus (P = 0.001) increased over the interval
between visits, whereas only calculus significantly in-
creased for Alzheimer subjects (P = 0.003). In general,
there were non-significant cross-sectional and longi-
tudinal trends of poorer gingival health with lower
MMSE scores, with two exceptions. With decreasing
MMSE scores, the percent of dental surfaces with
gingival bleeding (visit 1, r = -0.40, P = 0.06) and
plaque (visit 2, r = -0.52, P = 0.01) increased.
No statistical differences were seen between control
and AD subjects for any of the periodontal parameters
at visit 1 or at visit 2. In general, periodontal health
remained stable or improved slightly in both groups
over the time span. Pocket depth decreased signifi-
cantly over time in both control (P = 0.0001) and AD
subjects (P = 0.004), but there were no longitudinal
differences in the rate of decrease between the two
groups. LOA improved from visit 1 to visit 2 for
controls (P = 0.0001) but not for subjects with AD;
however, these differences over time between both
groups were not significant. The extent of teeth with
LOA decreased significantly for controls (P = 0.02) and
AD subjects (P = 0.006) over the time interval, and
this improvement was greater in subjects with AD (P
= 0.05). Furthermore, there were no significant corre-
lations between MMSE scores and periodontal param-
eters.
The cross-sectional and longitudinal analysis of total
number of remaining teeth and surfaces with coronal
and cervical caries revealed no statistical differences
between the two groups. The number of teeth with
restored coronal (visit 1, P = 0.006; visit 2, P = 0.03)
and cervical (visit I, P = 0.001; visit 2, P = 0.003)
surfaces was consistently higher in subjects with AD;
however, the longitudinal changes were not significant
for either population nor between groups (Figure 3).
Decayed-missing-filled-teeth score levels in subjects
with AD were significantly higher at visit 1 (P = 0.01)
and visit 2 (P = 0.04), although there was no significant
longitudinal change within either population or be-
tween the two groups (Table 2). The only dental pa-
rameter which was correlated significantly with MMSE
scores was the number of teeth with decayed coronal
surfaces. A negative correlation (r = -0.40, P = 0.06)
was found at visit 2 between coronal decay and MMSE
score.
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TABLE 2. 12-MONTH CHANGE IN ORAL HEALTH PARAMETERS*
Control Alzheimer's
Parameter Subjects vs 0** Subjects vs 0*** Controls vs Alzheimer's#
Salivary (rnl/min- gland)
Unstimulated parotid 0.010 0.04 0.006 NS 0.06
Stimulated parotid 0.003 NS -0.045 0.07 0.07
Unstim submandibular 0.007 NS 0.020 NS NS
Stirn submandibular 0.004 NS -0.027 NS NS
Gingival (%)
Dental plaque 2.90 0.0001 0.47 NS NS
Bleeding -0.72 NS 2.69 NS NS
Calculus 3.94 0.001 6.20 0.003 NS
Peridontal (mm)
Pocket depth -0.139 0.001 -0.126 0.004 NS
Recession 0.006 NS -0.003 NS NS
LOA## -0.095 0.001 -0.226 NS NS
Extent LOA (%) -1.99 0.02 -6.24 0.006 0.05
Severity LOA -0.009 NS -0.04 NS NS
Dental
Number of teeth -0.407 NS -0.243 NS NS
DMFT### 0.461 NS 0.347 NS NS
Decayed coronal 0.112 NS 0.050 NS NS
Decayed cervical -0.201 NS -0.027 NS NS
Restored coronal -0.003 NS -0.066 NS NS
Restored cervical 0.000 NS 0.001 NS NS
• Negative values denote a decrease over time, positivevalues denote an increase over time.
•• P valuesfor statistical comparison of control values versus no change from baseline (0).
••• P valuesfor statistical comparison of Alzheimervalues versus no change from baseline (0).
# P valuesfor statistical comparison of control andAlzheimer values.
## Level of attachment.
### Decayed-missing-filled-teeth score.
Intraoral mucosal examination showed no significant
differences between control and AD groups at either
visit. In addition, there were no significant changes in
oral mucosal health over time within or between the
two groups. Control (visits 1 and 2/ 43%) and AD (visit
1/40%; visit 2/ 67%) subjects with removable prosthe-
ses (full or partial dentures) were more likely to have
clinically detectable alterations in oral mucosa. There
was a significant negative correlation between MMSE
scores and oral mucosal health among denture-wearing
AD subjects (visit 2/ r = -0.97/ P < 0.01)/ but not
among non-denture-wearing subjects. The longitudi-
nal analysis revealed that decreasing MMSE scores
were correlated with diminished mucosal health for
denture-wearing (r = -0.62/ P < 0.01) and non-den-
ture-wearing (r = -0.43/ P = 0.06) AD subjects.
DISCUSSION
The results of this study demonstrate significant
differences in the oral health of unmedicated subjects
with Alzheimer's disease compared to age- and gender-
matched healthy, non-demented control subjects. In
general, these differences were observed in both cross-
sectional analyses, but not confirmed in the relatively
short (2 to 3 years) longitudinal span of the study.
Specifically, salivary gland flow rates (especially sub-
mandibular) were consistently lower in subjects with
AD. There was a greater history of dental disease
(increased dental restorations), more gingival disease,
but indistinguishable periodontal conditions in subjects
with AD compared with controls subjects. Oral mu-
cosal health was not different for the two groups;
however, denture-wearing subjects in both groups
showed altered mucosal health.
These cross-sectional results are consistent with pre-
viously reported findings of altered salivary gland
function, gingival health, and differences in dental
findings using a similar population of subjects who
were essentially healthy except for AD.s.6 However,
our longitudinal results overall did not reflect the cross-
sectional findings. Whereas stimulated salivary gland
flow rates decreased and gingival health and overall
dental disease worsened over the 2 to 3 years in sub-
jects with AD, the remaining oral health parameters
remained essentially stable. Nevertheless, many of the
oral health parameters examined indicated consistently
greater impairment among subjects with AD. Analyses
of rate of change in these parameters (Figures 1 to 3)
suggest that oral diseases will significantly impact on a
person's systemic health and quality of life sooner in
subjects with AD compared with control subjects. Fur-
thermore/ it can be expected that these subjects with
AD will be treated eventually for medical conditions
concomitant with the progression of AD and be pre-
scribed medications, many of which can have delete-
rious consequences to oral health."
Some form of oral hygiene was performed in the AD
subjects in this study because not all dental surfaces
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FIGURE 2. Longitudinal gingival parameters in 21 unmedicated AD
and 21 healthy control subjects. Gingival results are expressed as
percent of tooth surfaces examined with dental plaque (top panel),
gingival bleeding (middle panel), and calculus (bottom panel; mean
± SE). Values for AD subjects are extrapolated from the 1.9-year
time point to the 3-year time point.
FIGURE 3. Longitudinal dental parameters in 21 unmedicated AD
and 21 healthy control subjects. Results are expressed as number of
teeth with coronal restorations (top panel), number of teeth with
cervical restorations (middle panel), and the decayed-missing-filled-
teeth score (DMFT) (bottom panel; mean ± SE). Values for AD
subjects are extrapolated from the 1.9-year time point to the 3-year
time point.
were covered by dental plaque or had gingival bleeding
(Figure 2). Oral hygiene tasks, however, will probably
undergo significant change in the course of the disease.
These subjects were also community dwelling; the
extent of oral health care received by institutionalized
persons is generally lower and less frequent compared
to care received by subjects in this study. It can be
hypothesized that oral conditions of institutionalized
patients with AD and other medical problems, taking
numerous prescription medications, will deteriorate
more rapidly due to inadequate oral health care. There-
fore, the findings in this study of altered oral health in
community-dwelling, unmedicated subjects with early
AD may underestimate the eventual progression of
oral disease and impairment.
Saliva is essential for the maintenance of a healthy
oral environment, and diminished output may predis-
pose a person to multiple oral and systemic problems."
For example, diminished salivary function can predis-
pose a person to aspiration pneumonia." Major sali-
vary gland flow rates were consistently lower (with the
exception of stimulated parotid at visit 1), and stimu-
lated function diminished over time in subjects with
AD (Figure 1). These negative trends could be acceler-
ated if patients receive psychotropic or other anticho-
linergic drugs, which are frequently associated with
decreased salivary function."
The mechanisms underlying the diminished salivary
gland function in AD subjects are unclear. Secretion
by these glands is stimulated by activity of the saliva-
tory nuclei and is controlled by sympathetic and par-
asympathetic innervation. Parasympathetic stimula-
tion increases the volume of saliva secreted, whereas
sympathetic stimulation has greater effects on salivary
composition and protein content.32 The superior and
inferior saliva tory nuclei are located within the reticular
formation near the pontomedullary junction of the
brainstem and are in close proximity to the solitary
nucleus, which receives input from afferent taste fi-
bers.": 34 The salivatory nuclei receive innervation from
the corticoreticular tract, projecting from higher cortical
regions." which in tum receive most of their cholin-
ergic innervation from the nucleus basalis." It is known
that degeneration of the cholinerirc system33• 36-42 and
the nucleus basalis occurs in AD,3 .36 which could lead
to the inhibition of stimulus transduction to lower
levels of the brainstern, including the saliva tory and
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solitary nuclei. It is interesting to note that changes in
salivary output over time in subjects with AD were
more dramatic for citrate-stimulated compared with
unstimulated secretions (Table 2), which could partially
be due to concomitant alterations in gustatory func-
tion." Furthermore, there have been reports of brain-
stem degeneration, even within the reticular forma-
tion." in patients with AD. These findings, however,
are not consistent within an individual and between
persons with AD,45,46 and the heterogeneity of clinical
findings in these patients has been documented."
Therefore, the variable pattern of neuropathological
destruction could account for the variety of salivary
gland findings in these individuals,
The gingival health of AD subjects was considerably
worse than that of control subjects and deteriorated
with increased severity of dementia. Extrapolation of
dental plaque findings in subjects with AD indicates
that three-quarters of all tooth surfaces will be covered
with plaque 3 years from baseline (Figure 2). Less
attention is devoted to appearance and hygiene in
patients with early AD,48 and with the concomitant
decline in cognitive function, gingival health will prob-
ably continue to deteriorate, Gingivitis could eventu-
ally have systemic implications and predispose a per-
son to aspiration pneumonia." In contrast to the gin-
gival findings, the periodontal results demonstrated no
significant differences between subjects with AD and
controls. The six index teeth used in this study23 have
been shown to provide an accurate indication of gin-
gival health,50 but they may underestimate periodontal
disease progression." Perhaps the 2- to 3-year span of
the study was insufficient for gingivitis to increase
periodontitis markedly. Furthermore, there is evidence
to suggest that gingivitis may not necessarily be a
forerunner of periodontal diseases.52-55 Nevertheless,
the deterioration in gingival health eventually may lead
to significant periodontal destruction and tooth loss.
Dental conditions did not significantly worsen in
subjects with AD over the 2- to 3-year interval, yet
there was a consistently higher history of dental disease
among subjects with AD, as shown by higher decayed-
missing-filled-teeth scores and greater numbers of
teeth with restored coronal and cervical surfaces (Fig-
ure 3). The results also demonstrate that despite a
greater dental disease history, subjects with AD were
receiving dental care. It can be speculated, however,
that as cognitive and motor function deteriorate, and
these patients eventually become more impaired, they
will probably be less likely to perform regular oral
hygiene and seek dental treatment. Furthermore, the
risk for developing new or recurrent dental caries is
greatly increased in these patients because of dimin-
ished salivary gland output. It is unknown to what
magnitude dental caries must extend to produce an
abscess, bacteremia, or septicemia. Nevertheless, sub-
jects with AD have experienced a greater amount of
dental diseases compared with control subjects, despite
similar geographical and socio-economic backgrounds.
With a concomitant decrease in salivary gland function,
they are at an increased risk for developing caries and
its sequelae.
The overall condition of oral mucosal tissues was
similar between Alzheimer's subjects and control sub-
jects throughout the study. For both subject groups,
the denture-wearing subjects were more likely to dem-
onstrate clinical alterations in oral mucosa, which is
consistent with previous reports. 56, 57 The presence of
removable prostheses, rather than the diagnosis of AD,
is probably a greater prognosticator for oral mucosal
disorders. A general trend was seen for decreased
cognition and increased oral mucosal problems, which
indicates the need for care providers to remove pa-
tient's dentures at bedtime and to encourage routine
oral home care.
Preventive and treatment goals for individuals with
AD are to preserve and maintain oral health and func-
tion for as long as possible.J'"? Manual or mechanical
toothbrushing and flossing should be performed at
least daily and preferably after each meal, and dentures
should be cleaned and removed every night. Health
care providers, relatives, and friends should assist in
these measures if necessary, and can help identify new
problems necessitating appropriate consultation. Fluor-
idated dentifrices, water supplies, mouth rinses, and
topical gels are required to prevent dental caries, es-
pecially in patients with diminished salivary output.
These patients should also be encouraged to use sug-
arless candies, chewing gums and artificial salivas, and
should be monitored for oral fungal infections. Finally,
as long as a patient is able to cooperate during routine
dental treatment, frequent recall visits to dental profes-
sionals are necessary to assist in the prevention of oral
disease and to detect and treat problems before func-
tion is impaired.
Recommendations for optimum oral health care in
patients with AD include the necessity of establishing
relationships among dentists, dental hygienists, physi-
cians, nursing staff and other care-providers, as well
as family members and appropriate friends involved
in the regular care of the patient. This may increase
the likelihood of integrating daily oral health care into
other services provided by care-givers in community-
dwelling patients, or subjects residing in long-term care
facilities. The multidisciplinary approach to care of all
patients with dementia will assist both patients and
care-providers in the assessment of functional needs
and treatment goals.
A scientific account of the process of aging requires
a systematic approach to the role of disease in the
explanatiori." Therefore, more extensive longitudinal
studies involving subjects with well characterized dis-
eases are necessary to identify patients at risk for oral
diseases, to anticipate diagnostic and management
needs of the elderly, and to implement effective re~­
mens to prevent the development of oral problems.
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